US EditionCatheter Precision, Inc. Reports Results of Operations for Second Quarter 2025
ONTARIO, CANADA, AUG 11 – MAG Silver Corp. reported a 2% production increase at Juanicipio Mine and advanced exploration at Deer Trail and Larder Projects, with net income rising to $33,444 in Q2 2025.
- During Q2 2025, MAG commenced its Phase 1 drilling program at the Larder Project, which drilled 5,243 metres and confirmed major structures and significant gold intersections.
- At Juanicipio, 355,785 tonnes of ore were mined in Q2 2025, a 2% increase from Q2 2024, thanks to improved access and operational ramp-up, as reported by MAG Silver Corp.
- MAG Silver Corp.'s net income for Q2 2025 increased to $33,444, up from $21,614 in Q2 2024, attributed to higher metal prices and lower treatment charges.
14 Articles
14 Articles
Corsicana Daily Sun
Weatherford DemocratFaraday Copper Reports Second Quarter 2025 Financial Results
VANCOUVER, BC / ACCESS Newswire / August 11, 2025 / Faraday Copper Corp. ("Faraday" or the "Company") (TSX:FDY) announces its financial results for the three and six months ended June 30, 2025.
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“
Catheter Precision, Inc. Reports Results of Operations for Second Quarter 2025
FORT MILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced its results of operations for the…
The Toronto Star
WellandTribune.caMAG Silver Reports Second Quarter Financial Results
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) announces the Company’s unaudited consolidated financial results for the three months ended June 30, 2025 (“Q2 2025”). For details…
Cambridge Times
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial…
Coverage Details
Bias Distribution
- 75% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
